Processing 00000000.tx.1: Editorial: AutoImmune Premature Ovarian FailureEndocrine Aspects of a T Cell Disease1 Michael H. 

Phrase: "Editorial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282412:Editorial [Intellectual Product]

Phrase: ":"

Phrase: "AutoImmune Premature Ovarian FailureEndocrine Aspects of a T Cell Disease1 Michael H."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1547011:Aspect [Quantitative Concept]
   703   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.2: Melner and F. 

Phrase: "Melner"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: Alex Feltus1 Departments of Obstetrics & Gynecology and Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2515 Address all correspondence and requests for reprints to: Dr. 

Phrase: "Alex Feltus1 Departments of Obstetrics & Gynecology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0028775:Obstetrics Departments [Health Care Related Organization]
   767   C0587481:Gynaecology department [Health Care Related Organization]
   719   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Vanderbilt University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Nashville,"

Phrase: "Tennessee 37232-2515"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039514:Tennessee [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.4: Michael H. 

Phrase: "Michael H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.5: Melner, Department of Obstetrics & Gynecology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2515. 

Phrase: "Melner,"

Phrase: "Department of Obstetrics & Gynecology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0028775:Obstetrics Department [Health Care Related Organization]
   819   C0587481:Gynaecology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Vanderbilt University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Nashville,"

Phrase: "Tennessee 37232-2515."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039514:Tennessee [Geographic Area]
Processing 00000000.tx.6: E-mail: Mike.Melner{at}mcmail.vanderbilt.edu  Abstract Top Abstract Introduction References   Introduction Top Abstract Introduction References  Premature ovarian failure (POF) is the loss of ovarian function in women less than 40 yr of age (reviewed in Ref. 1). 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Mike.Melner{at}mcmail.vanderbilt.edu  Abstract Top Abstract Introduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1293116:Introduction [Health Care Activity]
   790   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Introduction Top Abstract Introduction"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Premature ovarian failure (POF)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
  1000   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
  1000   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   901   C0747102:Ovarian failure [Disease or Syndrome]
   827   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   827   C0205252:Premature [Temporal Concept]
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "the loss of ovarian function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in women less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "than 40 yr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439234:yr [Temporal Concept]

Phrase: "of age ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.7: It is associated with sex steroid deficiency, amenorrhea, infertility, and elevated serum gonadotropins. 

Phrase: "It"

Phrase: "is"

Phrase: "associated with sex steroid deficiency,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0009253:Sex [Organism Function]
   760   C0011155:Deficiency [Functional Concept]
   760   C0036864:Sex [Behavior]
   760   C0038317:Steroid [Steroid]
   760   C0079399:sex [Organism Attribute]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C1314687:Sex [Finding]
   760   C1522384:sex [Organism Attribute]
   760   C1623416:deficiency [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "amenorrhea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002453:Amenorrhea [Disease or Syndrome]

Phrase: "infertility,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0021359:Infertility [Disease or Syndrome]
   928 E C0232919:Infertile [Functional Concept]

Phrase: "and"

Phrase: "elevated serum gonadotropins."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1862265:Elevated gonadotropins [Finding]
   827   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793 E C3536870:Gonadotropin [Pharmacologic Substance]
Processing 00000000.tx.8: While there are multiple etiologies of POF including the exposure to iatrogenic treatments (chemotherapy, radiation), viral agents, and rare genetic disorders, in most patients no etiology can be identified (idiopathic POF). 

Phrase: "While"

Phrase: "there"

Phrase: "are"

Phrase: "multiple etiologies of POF"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0015127:etiologies [Functional Concept]
   719 E C1314792:Etiology [Functional Concept]
   719 E C1524003:Etiology [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the exposure to iatrogenic treatments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "(chemotherapy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
  1000   C0013217:chemotherapy [Functional Concept]
  1000   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "radiation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034519:Radiation [Natural Phenomenon or Process]
  1000   C0560559:Radiation [Quantitative Concept]
  1000   C0851346:Radiation [Natural Phenomenon or Process]
  1000   C1522449:Radiation [Therapeutic or Preventive Procedure]
  1000   C1524020:Radiation [Therapeutic or Preventive Procedure]
  1000   C1524021:Radiation [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "viral agents,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "rare genetic disorders,"
Meta Candidates (Total=22; Excluded=16; Pruned=0; Remaining=6)
   901   C0019247:Genetic Disorders [Disease or Syndrome]
   901   C2924406:Genetic disorders [Laboratory Procedure]
   896   C0678236:Rare disorder [Disease or Syndrome]
   873 E C0242354:birth disorders [Congenital Abnormality,Disease or Syndrome]
   859 E C0178829:Genital Disorders [Disease or Syndrome]
   827   C0012634:Disorders [Disease or Syndrome]
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "in most patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "no etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "can"

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(idiopathic POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: ")."
Processing 00000000.tx.9: Significant evidence suggests that autoimmunity is a cause of some forms of ovarian failure although specific ovarian antigens are not known and the mechanisms of autoimmune disease development are unclear. 

Phrase: "Significant evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004368:Autoimmunity [Pathologic Function]
   928 E C0443146:Autoimmune [Pathologic Function]

Phrase: "is"

Phrase: "a cause of some"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015127:cause [Functional Concept]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "forms of ovarian failure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0025322:Ovarian Failure [Disease or Syndrome]
   833   C0747102:Ovarian failure [Disease or Syndrome]
   770   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   770   C0231174:Failure [Functional Concept]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0680095:failure [Individual Behavior]
   770   C1522492:Form [Functional Concept]

Phrase: "although"

Phrase: "specific ovarian antigens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0456981:Specific antigens [Immunologic Factor]
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "and"

Phrase: "the mechanisms of autoimmune disease development"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "unclear."
Processing 00000000.tx.10: Autoimmune POF in humans is frequently associated with other manifestations of autoimmune disease. 

Phrase: "Autoimmune POF in humans"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   833   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   833   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   790   C0747102:Ovarian failure [Disease or Syndrome]
   753   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   753   C0205252:Premature [Temporal Concept]
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "associated with other manifestations of autoimmune disease."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0004364:Autoimmune Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0243083:associated disease [Pathologic Function]
   762   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205319:manifestations [Functional Concept]
   748   C0443146:Autoimmune [Pathologic Function]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.11: For example, POF can precede the onset of Addisons disease or adrenal autoimmunity leading to a deficiency of adrenocortical hormones (1). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
  1000   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
  1000   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   901   C0747102:Ovarian failure [Disease or Syndrome]
   827   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   827   C0205252:Premature [Temporal Concept]
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "can"

Phrase: "precede"

Phrase: "the onset of Addisons disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0277793:disease onset [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "adrenal autoimmunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004368:Autoimmunity [Pathologic Function]
   789 E C0443146:Autoimmune [Pathologic Function]

Phrase: "leading to a deficiency of adrenocortical hormones"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   774   C0599750:deficiency hormones [Disease or Syndrome]
   748   C0011155:Deficiency [Functional Concept]
   748   C0019932:Hormones [Hormone]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0332152:Leading [Temporal Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1623416:deficiency [Qualitative Concept]
   748   C2986474:Adrenocortical [Qualitative Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Autoimmune POF is characterized by inflammatory infiltration of developing follicles, production of anti-ovarian antibodies, atrophy, and sparing of primordial follicles (1, 2, 3). 

Phrase: "Autoimmune POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "characterized by inflammatory infiltration of developing follicles,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0302158:Inflammatory infiltration [Pathologic Function]
   748   C0018120:Follicles [Body Part, Organ, or Organ Component]
   748   C0221971:Follicles [Body Part, Organ, or Organ Component]
   748   C0332448:Infiltration [Pathologic Function]
   748   C0333348:Inflammatory [Functional Concept]
   748   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   748   C1523986:Infiltration [Functional Concept]
   748   C1880022:Characterized [Activity]
   714 E C1571705:Follicle [Body Part, Organ, or Organ Component]

Phrase: "production of anti-ovarian antibodies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0003261:antibodies production [Biologic Function]
   760   C0033268:production [Occupational Activity]

Phrase: "atrophy,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333641:Atrophy [Pathologic Function]
   928 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "sparing of primordial follicles"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Autoantibodies in these diseases sometimes react with common antigens in steroid-producing cells of the ovary and adrenal cortex. 

Phrase: "Autoantibodies in these diseases sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "react with common antigens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003320:Antigens [Immunologic Factor]
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "in steroid-producing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "of the ovary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "adrenal cortex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001613:Adrenal Cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]
Processing 00000000.tx.14: Common antigens identified have been steroidogenic enzymes including P450 side-chain cleavage (P450scc), 17-hydroxylase, and 3-hydroxysteroid dehydrogenase (4, 5, 6). 

Phrase: "Common antigens"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0003320:Antigens [Immunologic Factor]
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "steroidogenic enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "P450 side-chain cleavage (P450scc),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]

Phrase: "17-hydroxylase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038302:17-Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "3-hydroxysteroid dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0000413:3-hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0020392:hydroxysteroid dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020393:hydroxysteroid [Steroid]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.15: The identification of specific antigens involved in POF is important for multiple reasons. 

Phrase: "The identification of specific antigens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "involved in POF"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   862   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   862   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   806   C0747102:Ovarian failure [Disease or Syndrome]
   760   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   760   C0205252:Premature [Temporal Concept]
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]
   760   C1314939:Involved [Functional Concept]

Phrase: "is"

Phrase: "important for multiple reasons."
Processing 00000000.tx.16: First, the development of appropriate reagents to screen for the presence of antibodies to these antigens could provide an analytical tool for diagnosing the disease, identifying patients at risk for developing the disease, and detecting patients who may respond to immune-modulating therapies. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the development of appropriate reagents to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "screen for the presence of antibodies"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0368676:antibodies screen [Laboratory Procedure]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0220908:screen [Health Care Activity]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to these antigens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an analytical tool for diagnosing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0336791:Tool [Manufactured Object]
   760   C2827396:Tool [Manufactured Object]

Phrase: "the disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "identifying"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "at risk for developing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1444641:At risk [Qualitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C1516077:At [Spatial Concept]

Phrase: "the disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "detecting patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "may"

Phrase: "respond to immune-modulating therapies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0087111:therapies [Therapeutic or Preventive Procedure]
   760   C0439662:Immune [Functional Concept]
   760   C0443264:Modulating [Spatial Concept]
   726 E C0039798:therapy [Functional Concept]
   726 E C1363945:Therapy [Finding]
Processing 00000000.tx.17: Second, these tools could be used in research to further understand the mechanisms of disease development and the mechanisms of ovarian pathology associated with the disease. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "these tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0336791:Tool [Manufactured Object]
   966   C2827396:Tool [Manufactured Object]

Phrase: "could"

Phrase: "be"

Phrase: "used in research"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0035168:research [Research Activity]
   790   C0242481:Research [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the mechanisms of disease development"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "the mechanisms of ovarian pathology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "associated with the disease."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.18: Lastly, the identification of these antigens provides new information on novel proteins in the ovary and their potential function. 

Phrase: "Lastly,"

Phrase: "the identification of these antigens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "new information on novel proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C3242228:new information [Intellectual Product]
   760   C1533716:Information [Idea or Concept]

Phrase: "in the ovary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "their potential function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.19: Animal models of autoimmune premature ovarian failure have yielded important insight into both potential mechanisms of autoimmune disease development and ovarian antigens that may affect disease progression. 

Phrase: "Animal models of autoimmune premature ovarian failure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0599779:Models, Animal [Animal]
   748   C0003062:Animal [Animal]
   748   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "yielded important insight into both potential mechanisms of autoimmune disease development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0233820:Insight [Mental Process]

Phrase: "and"

Phrase: "ovarian antigens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigens [Immunologic Factor]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "that"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "disease progression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242656:Disease Progression [Pathologic Function]
           progression
  1000   C1947900:Disease progression NOS [Finding]
   861   C0449258:Progression [Functional Concept]
Processing 00000000.tx.20: These models for autoimmune ovarian failure can be induced by multiple methods such as immunization with specific ovarian antigens or neonatal thymectomy in specific genetic strains of mice. 

Phrase: "These models for autoimmune ovarian failure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Models [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "induced by multiple methods"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0205263:Induced [Functional Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "such as immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with specific ovarian antigens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0456981:Specific antigens [Immunologic Factor]
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "or"

Phrase: "neonatal thymectomy in specific genetic strains of mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040071:Thymectomy [Therapeutic or Preventive Procedure]
   744   C2945605:Thymectomy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.21: A detailed review of the findings will not be repeated here but some major developments will be summarized. 

Phrase: "A detailed review of the findings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0282443:Review [Intellectual Product]
   753   C1552617:Review [Idea or Concept]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "here"

Phrase: "but"

Phrase: "some major developments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   777 E C0458003:Developmental [Qualitative Concept]

Phrase: "will"

Phrase: "be"

Phrase: "summarized."
Processing 00000000.tx.22: The most important development in these animal models of autoimmune ovarian failure comes from multiple studies, all suggesting that the basis of the disease is a cell-mediated autoimmune reaction caused by an alteration in T cell regulation (1, 3). 

Phrase: "The most important development in these animal models of autoimmune ovarian failure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C1160265:ovarian development [Organ or Tissue Function]
   736   C0243107:development [Physiologic Function]
   736   C0678723:Development [Organism Function]
   736   C1527148:Development [Functional Concept]
   734   C0920595:development model [Intellectual Product]

Phrase: "comes from multiple studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439064:Multiple [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "all"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the basis of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "a cell-mediated autoimmune reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0443146:Autoimmune reaction [Pathologic Function]
   840   C1963070:Autoimmune reaction [Finding]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]

Phrase: "caused by an alteration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1515926:Alteration [Idea or Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in T cell regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0039194:T-cell [Cell]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.23: This is most evident in the neonatal thymectomy animal model. 

Phrase: "This"

Phrase: "is"

Phrase: "most evident in the neonatal thymectomy animal model."
Processing 00000000.tx.24: The removal of the thymus in specific genetic strains of mice (e.g. BALB/c or A/J) between postnatal days 2 and 5 results in autoimmune ovarian failure. 

Phrase: "The removal of the thymus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0040071:thymus removal [Therapeutic or Preventive Procedure]
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "in specific genetic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0596615:genetic strain [Biologic Function]
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "("

Phrase: "e.g. BALB/c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: "or"

Phrase: "A/J) between postnatal days 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1510707:A/J [Mammal]
   767   C0456647:J/day [Quantitative Concept]

Phrase: "and"

Phrase: "5 results in autoimmune ovarian failure."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.25: There is a progressive onset of the disease that is potentiated by puberty and the most severe inflammation occurs between 414 weeks after thymectomy (3). 

Phrase: "There"

Phrase: "is"

Phrase: "a progressive onset of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0277793:disease onset [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "potentiated by puberty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034011:Puberty [Physiologic Function]

Phrase: "and"

Phrase: "the most severe inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0522569:Severe inflammation [Finding]
   827   C0021368:Inflammation [Pathologic Function]

Phrase: "occurs between 414 weeks"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439230:weeks [Temporal Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "after thymectomy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040071:Thymectomy [Therapeutic or Preventive Procedure]
  1000   C2945605:Thymectomy [Therapeutic or Preventive Procedure]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: The proposed mechanism of the disease (3) is that autoreactive T cells (CD4+) are generated during normal processes such as apoptosis of follicles in the ovary. 

Phrase: "The proposed mechanism of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "is"

Phrase: "that autoreactive T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(CD4+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: ")"

Phrase: "are"

Phrase: "generated during normal processes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   770   C3146294:Generated [Activity]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "such as apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "of follicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0018120:Follicles [Body Part, Organ, or Organ Component]
  1000   C0221971:Follicles [Body Part, Organ, or Organ Component]
   966 E C1571705:Follicle [Body Part, Organ, or Organ Component]
   916 E C0439682:Follicular [Qualitative Concept]

Phrase: "in the ovary."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]
Processing 00000000.tx.27: These autoreactive cells are normally controlled by CD4+ T cells with suppressor activity. 

Phrase: "These autoreactive cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "normally"

Phrase: "controlled by CD4+ T cells"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   806   C0039194:T-Cells [Cell]
   806   C0332298:Controlled by [Functional Concept]
   797   C0039215:cd4 cells [Cell]
   797   C3251824:Cells.CD4 [Cell]
   760   C0007634:Cells [Cell]
   760   C2587213:Controlled [Functional Concept]
   760   C3282337:Cells [Cell]
   760   C3541261:CD4 [Laboratory Procedure]
   726 E C0243148:control [Qualitative Concept]
   726 E C1269647:Cell [Cell]
   726 E C1550141:Control [Substance]
   726 E C1704653:Cell [Medical Device]
   726 E C1882979:Control [Conceptual Entity]
   726 E C1948049:Cell [Spatial Concept]
   726 E C3274648:Control [Qualitative Concept]

Phrase: "with suppressor activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.28: However, because these cells are generated in the thymus after the first week of life, neonatal thymectomy results in a dramatic loss in T cells with suppressor function. 

Phrase: "However,"

Phrase: "because"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "generated in the thymus"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040113:Thymus [Body Part, Organ, or Organ Component]
   770   C1015036:Thymus [Plant]
   770   C1515430:THYMUS [Tissue]
   770   C3146294:Generated [Activity]
   715 E C1306748:Thymus gland [Body Part, Organ, or Organ Component]

Phrase: "after the first week"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: "of life,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "neonatal thymectomy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040071:Thymectomy [Therapeutic or Preventive Procedure]
   861   C2945605:Thymectomy [Therapeutic or Preventive Procedure]

Phrase: "results in a dramatic loss"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1274040:Result [Functional Concept]
   760   C1517945:Loss [Quantitative Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with suppressor function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.29: This animal model strongly implicates T cell regulation in the disease process. 

Phrase: "This animal model strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599779:Animal Model [Animal]
   827   C0003062:Animal [Animal]
   827   C3161035:Model [Intellectual Product]

Phrase: "implicates"

Phrase: "T cell regulation in the disease process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.30: Further support for the role of T cell regulation comes from other animal models of autoimmune POF. 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support for the role of T cell regulation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0039194:T-cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0035820:Role [Social Behavior]
   744   C0183683:Support [Medical Device]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1269647:Cell [Cell]
   744   C1327622:Regulation [Biologic Function]
   744   C1521721:Support [Conceptual Entity]
   744   C1704653:Cell [Medical Device]
   744   C1705810:Role [Conceptual Entity]
   744   C1948049:Cell [Spatial Concept]

Phrase: "comes from other animal models of autoimmune POF."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   782   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   782   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   760   C0599779:Models, Animal [Animal]
   760   C0747102:Ovarian failure [Disease or Syndrome]
   739   C0003062:Animal [Animal]
   739   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   739   C0205252:Premature [Temporal Concept]
   739   C0231174:Failure [Functional Concept]
   739   C0443146:Autoimmune [Pathologic Function]
   739   C0680095:failure [Individual Behavior]
   739   C3161035:Models [Intellectual Product]
Processing 00000000.tx.31: It is now clear that ovarian failure is induced in animals treated with ovarian antigens (1) such as zona pellucida protein 3 (ZP3). 

Phrase: "It"

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that ovarian failure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025322:Ovarian Failure [Disease or Syndrome]
  1000   C0747102:Ovarian failure [Disease or Syndrome]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "induced in animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003062:Animals [Animal]
   790   C0205263:Induced [Functional Concept]

Phrase: "treated with ovarian antigens"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0003320:Antigens [Immunologic Factor]
   770   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "such as zona pellucida protein 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043519:Zona Pellucida [Cell Component]
   812   C0019360:Zona [Disease or Syndrome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(ZP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597698:ZP3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421866:ZP3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.32: However, there is significant evidence indicating that autoimmune POF can develop with antigen treatment, even if the antigen is not related to known ovarian antigens. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "significant evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicating"

Phrase: "that autoimmune POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: "can"

Phrase: "develop with antigen treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0003320:Antigen [Immunologic Factor]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "even"

Phrase: "if"

Phrase: "the antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to known ovarian antigens."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003320:Antigens [Immunologic Factor]
   760   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   760   C0205309:Known [Qualitative Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.33: This suggests that the process of T cell activation can sometimes result in a loss of T cell regulation and the subsequent activation of autoreactive T cells (3). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the process of T cell activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0007613:Cell Process [Cell Function]
   783   C0230625:Cell process [Cell Component]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]

Phrase: "can"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "result in a loss of T cell regulation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0039194:T-cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1269647:Cell [Cell]
   744   C1274040:Result [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1517945:Loss [Quantitative Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the subsequent activation of autoreactive T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C1155065:T-Cell Activation [Cell Function]
   774   C1326120:activation cells [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.34: The genetic susceptibility to the development of autoimmune POF may ultimately provide some key insight into the mechanisms involved. 

Phrase: "The genetic susceptibility to the development of autoimmune POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0314657:Genetic Susceptibility [Organism Attribute]
   738   C0012655:Susceptibility [Clinical Attribute]
   738   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   738   C0220898:Susceptibility [Organism Attribute]
   738   C0314603:Genetic [Functional Concept]
   738   C1264642:Susceptibility [Functional Concept]
   738   C1547045:*Susceptibility [Quantitative Concept]
   726   C0151526:Premature Birth [Pathologic Function]
   712   C1820234:genital development [Biologic Function]

Phrase: "may"

Phrase: "ultimately"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "some key insight into the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:Insight [Mental Process]

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.35: Previous studies have demonstrated a genetic component to human POF that could be documented across multiple generations (7, 8). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "a genetic component to human POF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "documented across multiple generations"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0079411:Generations [Temporal Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]
   737 E C3146294:Generation [Activity]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.36: In the autoimmune POF induced by neonatal thymectomy in genetically susceptible strains of mice, the locus that controls this phenotype (Aod2) has been mapped to mouse chromosome 3 (9). 

Phrase: "In the autoimmune POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: "induced by neonatal thymectomy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0040071:Thymectomy [Therapeutic or Preventive Procedure]
   770   C0205263:Induced [Functional Concept]
   770   C1552240:Neonatal [Professional or Occupational Group]
   770   C1552264:Neonatal [Professional or Occupational Group]
   770   C2939425:Neonatal [Temporal Concept]
   770   C2945605:Thymectomy [Therapeutic or Preventive Procedure]

Phrase: "in genetically susceptible strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "of mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "the locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "that"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "this phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Aod2"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "mapped to mouse chromosome 3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0008666:Chromosome 3 [Cell Component]
   781   C0814036:chromosome map [Intellectual Product]
   760   C0008633:Chromosome [Cell Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.37: Interestingly, the Aod2 locus colocalizes with Idd3, a gene that is involved in the susceptibility to autoimmune insulin-dependent type 1 diabetes mellitus in the nonobese diabetic mouse (9). 

Phrase: "Interestingly,"

Phrase: "the Aod2 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "colocalizes with Idd3,"

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "involved in the susceptibility"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to autoimmune insulin-dependent type 1 diabetes mellitus"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   891   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Diabetes Mellitus, Type 1
           Insulin Dependent Diabetes
           Type 1 diabetes
   877   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   877   C2984334:Type I diabetes mellitus [Functional Concept]
   829   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   829   C1320657:type diabetes [Finding]
   818   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   818   C0441729:Type 1 [Classification]
   795   C0011847:Diabetes [Disease or Syndrome]
   795   C0332307:Type [Qualitative Concept]
   795   C1547052:*Type [Quantitative Concept]

Phrase: "in the nonobese diabetic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mouse [Mammal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.38: This suggests the potential involvement of a common locus in these two autoimmune responses. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the potential involvement of a common locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in these two autoimmune responses."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004366:Autoimmune Responses [Pathologic Function]
   827   C0443146:Autoimmune [Pathologic Function]
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]
Processing 00000000.tx.39: The paper by Tong and Nelson (10) describes the identification and cloning of a complementary DNA (cDNA) encoding a protein that is a major antigen in the neonatal thymectomized mouse model of autoimmune premature ovarian failure. 

Phrase: "The paper by Tong"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030351:Paper [Manufactured Object]
   770   C1547566:Paper [Idea or Concept]

Phrase: "and"

Phrase: "Nelson"

Phrase: "(10"

Phrase: ")"

Phrase: "describes"

Phrase: "the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "cloning of a complementary DNA (cDNA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009015:Cloning [Research Activity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "a major antigen in the neonatal thymectomized mouse model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0348042:A antigen [Immunologic Factor]
   762   C1455722:Mouse antigen [Immunologic Factor]
   742   C0003320:Antigen [Immunologic Factor]

Phrase: "of autoimmune premature ovarian failure."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]
Processing 00000000.tx.40: The studies are interesting in the new information they provide and for the potential new research tools they generate. 

Phrase: "The studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "interesting in the new information"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C3242228:new information [Intellectual Product]
   760   C0205314:New [Temporal Concept]
   760   C0543488:interesting [Mental Process]
   760   C1533716:Information [Idea or Concept]

Phrase: "they"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "and for the potential new research tools"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0035168:research [Research Activity]
   748   C0205314:New [Temporal Concept]
   748   C0242481:Research [Research Activity]
   748   C1515981:And [Idea or Concept]
   748   C3245505:Potential [Qualitative Concept]
   714   C0336791:Tool [Manufactured Object]
   714   C2827396:Tool [Manufactured Object]

Phrase: "they"

Phrase: "generate."
Processing 00000000.tx.41: On a basic level, a new gene product (designated ooplasm-specific protein 1, OP1) has been identified that appears to be specific for the oocyte. 

Phrase: "On a basic level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "a new gene product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0681520:new product [Intellectual Product,Manufactured Object]
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "(designated ooplasm-specific protein 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205369:Specific [Qualitative Concept]
   804   C1552740:specific [Intellectual Product]

Phrase: "OP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083867:OP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332428:OP1 [Gene or Genome]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specific for the oocyte."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
Processing 00000000.tx.42: While the sequence of OP1 was not homologous to any known cDNAs/proteins and the function of the protein is not yet known, it contains some potentially relevant amino acid sequence motifs suggesting ATP/GTP-binding and phosphorylation sites for protein kinases. 

Phrase: "While"

Phrase: "the sequence of OP1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "not homologous to any known cDNAs/proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1512488:Homologous Protein [Amino Acid, Peptide, or Protein]
   748   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "the function of the protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0815043:function protein [Amino Acid, Peptide, or Protein]
   797   C1527118:Protein Function [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "it"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "some potentially relevant amino acid sequence motifs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0752190:Amino Acid Motifs [Spatial Concept]
   766   C1514562:Motif [Amino Acid Sequence]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "ATP/GTP-binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1148923:ATP binding [Molecular Function]
   901   C1149035:GTP Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "phosphorylation sites for protein kinases."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   797   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   773   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.43: Follow-up studies on the function of OP1 are apparently underway and OP1 may provide new insight into the mechanisms controlling oocyte maturation and fertilization. 

Phrase: "Follow-up studies on the function of OP1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   800   C0016441:Follow-Up Studies [Research Activity]
   770   C0589120:Follow-up [Finding]
   770   C1522577:follow-up [Health Care Activity]
   770   C1704685:FOLLOW-UP [Intellectual Product]
   770   C3274571:FOLLOW-UP [Health Care Activity]
   744   C0332283:follow [Temporal Concept]
   744   C0947630:studies [Laboratory Procedure]
   744   C1719822:Follow [Intellectual Product]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "apparently underway"

Phrase: "and"

Phrase: "OP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083867:OP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332428:OP1 [Gene or Genome]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new insight into the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:Insight [Mental Process]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "oocyte maturation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1160520:oocyte maturation [Cell Function]
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "fertilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015914:Fertilisation [Organism Function]
Processing 00000000.tx.44: The identification of OP1 also provides some potentially important research tools for examining the onset and development of autoimmune POF. 

Phrase: "The identification of OP1 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "some potentially important research tools for examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0336791:Tool [Manufactured Object]
   714   C2827396:Tool [Manufactured Object]

Phrase: "the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "development of autoimmune POF."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1160265:ovarian development [Organ or Tissue Function]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
Processing 00000000.tx.45: For example, OP1 protein obtained from expression systems could be used to detect the presence and levels of circulating antibodies and the time-course of their appearance. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "OP1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "obtained from expression systems"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1301820:Obtained [Functional Concept]
   737   C0449913:System [Functional Concept]
   737   C1553451:System [Manufactured Object]
   737   C1704459:System [Medical Device]
   737 E C1706701:Obtain [Activity]

Phrase: "could"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "levels of circulating antibodies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the time-course of their appearance."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.46: Autoreactive T cells and B-cells could be characterized and changes in the subpopulations of T cells examined closely to further elucidate mechanisms of disease progression. 

Phrase: "Autoreactive T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "B-cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "changes in the subpopulations of T cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0039194:T-Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714   C1257890:Subpopulation [Population Group]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "closely to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1517331:Further [Spatial Concept]
   793 E C0205108:far [Spatial Concept]

Phrase: "elucidate"

Phrase: "mechanisms of disease progression."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.47: In addition, the role of immune cells within the ovary can be better assessed with the use of reagents that recognize known target antigens. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the role of immune cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "within the ovary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "can"

Phrase: "be"

Phrase: "better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]

Phrase: "assessed with the use of reagents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1524063:Use of [Functional Concept]
   753   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1516048:Assessed [Activity]
   753   C1947944:Use [Intellectual Product]

Phrase: "that"

Phrase: "recognize"

Phrase: "known target antigens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003320:Antigens [Immunologic Factor]
   721 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.48: Another question in POF is the mechanism of antigen exposure and presentation in normal control animals and how the immune tolerance is converted to an active T cell response. 

Phrase: "Another question in POF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "the mechanism of antigen exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "presentation in normal control animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449450:Presentation [Idea or Concept]

Phrase: "and"

Phrase: "how"

Phrase: "the immune tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0020963:Immune Tolerance [Pathologic Function]
           Tolerance
   861   C0013220:Tolerance [Finding]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C0439662:Immune [Functional Concept]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "is"

Phrase: "converted to an active T cell response."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0039194:T-cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0205177:Active [Functional Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1269647:Cell [Cell]
   748   C1704632:Response [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1706817:Response [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]
   748   C2911692:Response [Mental Process]
Processing 00000000.tx.49: The fate of the majority of follicles in the ovary is atresia by apoptosis (11, 12, 13) and it is possible that one mechanism by which ovarian antigens are exposed to the immune system is during some segment of these processes. 

Phrase: "The fate of the majority of follicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1539479:FATE [Gene or Genome]

Phrase: "in the ovary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029939:Ovary [Body Part, Organ, or Organ Component]
  1000   C0227898:ovary [Body Part, Organ, or Organ Component]
  1000   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "atresia by apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243066:Atresia [Congenital Abnormality]

Phrase: "(11,"

Phrase: "12,"

Phrase: "13"

Phrase: ")"

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that one mechanism by which ovarian antigens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "exposed to the immune system"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0020962:Immune system [Body System]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C1291764:IMMUNE SYSTEM [Finding]
   760   C0439662:Immune [Functional Concept]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "is during some segment of these processes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441635:Segment [Spatial Concept]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.50: The oocyte presents a very interesting model of apoptosis since oocytes are surrounded by the cumulus layer of granulosa cells and bidirectional communication occurs via gap junctions between these 2 cell types. 

Phrase: "The oocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029045:Oocyte [Cell]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "a very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "model of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3161035:Model [Intellectual Product]

Phrase: "since"

Phrase: "oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029045:Oocytes [Cell]

Phrase: "are"

Phrase: "surrounded by the cumulus layer of granulosa cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   793   C1956101:Granulosa Cells, Cumulus [Cell]
           Cumulus Cells
   770   C0018207:Granulosa Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0934502:Layer [Body Part, Organ, or Organ Component]
   744   C1282914:Surrounded [Spatial Concept]
   744   C1522408:Layer [Qualitative Concept]
   744   C1561599:Layer [Intellectual Product]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "bidirectional communication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009452:Communication [Social Behavior]

Phrase: "occurs via gap junctions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0206117:Gap Junctions [Body Space or Junction]
   799 E C2984290:Gap junction [Functional Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737   C0205144:Junction [Spatial Concept]
   737   C1706311:Junction [Medical Device]

Phrase: "between these 2 cell types."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
   827   C0332307:Types [Qualitative Concept]
   793 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.51: This raises questions as to whether there is something unique about this cell communication structure that makes it susceptible to immune exposure during apoptosis. 

Phrase: "This"

Phrase: "raises"

Phrase: "questions as to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "something unique about this cell communication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710548:Unique [Qualitative Concept]

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "that"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it susceptible to immune exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231204:Susceptible [Functional Concept]
   760   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "during apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.52: Another mechanism of antigen exposure is during an inflammatory reaction. 

Phrase: "Another mechanism of antigen exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "is during an inflammatory reaction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021368:Inflammatory reaction [Pathologic Function]
   760   C0333348:Inflammatory [Functional Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.53: Such a reaction could occur at sites of ovulation when there is evidence of a local inflammatory response and the release of cumulus granulosa cell-oocyte complexes. 

Phrase: "Such"

Phrase: "a reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "could"

Phrase: "occur at sites of ovulation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C2945843:Site of [Qualitative Concept]
   760   C0029965:Ovulation [Organ or Tissue Function]
   760   C0205145:Sites [Spatial Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "when"

Phrase: "there"

Phrase: "is"

Phrase: "evidence of a local inflammatory response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "the release of cumulus granulosa cell-oocyte complexes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.54: Any inefficiency in oocyte release could see degenerating oocyte-granulosa cell complexes in the presence of inflammation-associated immune cells, some of which are antigen-presenting cells (e.g. macrophages). 

Phrase: "Any inefficiency in oocyte release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0231184:Inefficiency [Finding]

Phrase: "could"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "degenerating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011164:degenerating [Pathologic Function]
   966 E C1880269:Degenerate [Functional Concept]

Phrase: "oocyte-granulosa cell complexes in the presence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1704241:Complexes [Chemical Viewed Structurally]
   714 E C0439855:Complex [Qualitative Concept]

Phrase: "of inflammation-associated immune cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "are"

Phrase: "antigen-presenting cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003315:Antigen-Presenting Cells [Cell]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0007634:Cells [Cell]
   827   C0449450:Presenting [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C0150312:Present [Quantitative Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "("

Phrase: "e.g. macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: ")."
Processing 00000000.tx.55: It is interesting to note that puberty and the presence of increased serum gonadotropins appears to enhance the autoimmune response in experimental models of autoimmune POF (3). 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that puberty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034011:Puberty [Physiologic Function]

Phrase: "and"

Phrase: "the presence of increased serum gonadotropins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the autoimmune response in experimental models of autoimmune POF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0004366:Autoimmune Response [Pathologic Function]
   738   C0443146:Autoimmune [Pathologic Function]
   738   C0871261:Response [Organism Attribute]
   738   C1704632:Response [Finding]
   738   C1706817:Response [Intellectual Product]
   738   C2911692:Response [Mental Process]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.56: The new reagents generated by these studies could be used to help examine the onset of autoreactive antibodies and T cells. 

Phrase: "The new reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "generated by these studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0947630:studies [Laboratory Procedure]
   770   C3146294:Generated [Activity]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "could"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "examine"

Phrase: "the onset of autoreactive antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "T cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.57: The exact mechanisms of pathology in autoimmune POF are not clearly defined. 

Phrase: "The exact mechanisms of pathology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "in autoimmune POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: "are"

Phrase: "not clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.58: The neonatal thymectomized mouse model coupled with a known major antigen provides a system to begin to understand the cellular processes of ovarian failure. 

Phrase: "The neonatal thymectomized mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]

Phrase: "coupled with a known major antigen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0003320:Antigen [Immunologic Factor]
   753   C0205164:Major [Qualitative Concept]
   753   C0205309:Known [Qualitative Concept]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the cellular processes of ovarian failure."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0007613:Cellular Process [Cell Function]
   773   C1325880:cellular process [Cell Function]
   719   C1184743:Process [Body Part, Organ, or Organ Component]
   719   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.59: The time-course of the development of antibodies to OP1 during autoimmune ovarian failure is not known. 

Phrase: "The time-course of the development of antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449247:Time course [Temporal Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0750729:Course [Temporal Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: "to OP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083867:OP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332428:OP1 [Gene or Genome]

Phrase: "during autoimmune ovarian failure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0025322:Ovarian Failure [Disease or Syndrome]
   901   C0747102:Ovarian failure [Disease or Syndrome]
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.60: For example, are OP1 antibodies amplified early in the process or are do they occur late after significant inflammatory damage. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "are"

Phrase: "OP1 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "amplified"

Phrase: "early in the process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1279919:Early [Temporal Concept]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "or"

Phrase: "are"

Phrase: "do"

Phrase: "they"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "late after significant inflammatory damage."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0010957:Damage [Injury or Poisoning]
   760   C0205087:Late [Temporal Concept]
   760   C0237881:significant [Quantitative Concept]
   760   C0333348:Inflammatory [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1883709:Damage [Functional Concept]
Processing 00000000.tx.61: Closely related to the question of time-course, it is not known whether OP1 antibodies play a role in the etiology of ovarian failure. 

Phrase: "Closely"

Phrase: "related to the question of time-course,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0449247:Time course [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0750729:Course [Temporal Concept]
   748   C1522634:Question [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "whether"

Phrase: "OP1 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the etiology of ovarian failure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.62: The similarities/differences between the neonatal thymectomized mouse model of autoimmune POF and the autoimmune POF seen in humans are difficult to assess. 

Phrase: "The similarities/differences between the neonatal thymectomized mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "of autoimmune POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "the autoimmune POF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: "seen in humans"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0086418:Humans [Human]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "are"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "assess."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]
Processing 00000000.tx.63: There appear to be methodological problems in the immunodetection of antigens, particularly using cross-species studies. 

Phrase: "There"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "methodological problems in the immunodetection of antigens,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1546466:Problems [Idea or Concept]
   714 E C0033213:Problem [Finding]

Phrase: "particularly"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cross-species studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
Processing 00000000.tx.64: By identifying a major antigen OP1 in murine autoimmune POF, it is now possible to screen for the homologous human antigen. 

Phrase: "By identifying"

Phrase: "a major antigen OP1 in murine autoimmune POF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0083867:OP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1332428:OP1 [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "now possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C1948052:Now [Temporal Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "screen for the homologous human antigen."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0312561:Homologous antigen [Immunologic Factor]
   753   C0003320:Antigen [Immunologic Factor]
   753   C0086418:Human [Human]
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1334043:Homologous [Gene or Genome]
   753   C1705053:Screen [Medical Device]
Processing 00000000.tx.65: If this presents problems using antisera, a homologous human cDNA could be isolated and used to express protein and develop detection methods for the presence of antibodies in women with autoimmune POF. 

Phrase: "If"

Phrase: "this"

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1546466:Problems [Idea or Concept]
   966 E C0033213:Problem [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisera,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a homologous human cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "could"

Phrase: "be"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "develop"

Phrase: "detection methods for the presence of antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   789   C0449335:Method of detection [Intellectual Product]
           detection methods
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "with autoimmune POF."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   923   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   923   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   861   C0747102:Ovarian failure [Disease or Syndrome]
   812   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   812   C0205252:Premature [Temporal Concept]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]
Processing 00000000.tx.66: Ultimately, stringent methods can be brought to task to determine whether an homologous antigen is involved in human autoimmune POF. 

Phrase: "Ultimately,"

Phrase: "stringent methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "brought to task to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332302:brought [Functional Concept]
   770   C3540678:Task [Occupational Activity]

Phrase: "determine"

Phrase: "whether"

Phrase: "an homologous antigen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0312561:Homologous antigen [Immunologic Factor]
   861   C0003320:Antigen [Immunologic Factor]
   861   C1334043:Homologous [Gene or Genome]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "is"

Phrase: "involved in human autoimmune POF."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   814   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   814   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   778   C0747102:Ovarian failure [Disease or Syndrome]
   748   C0086418:Human [Human]
   748   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   748   C0205252:Premature [Temporal Concept]
   748   C0231174:Failure [Functional Concept]
   748   C0443146:Autoimmune [Pathologic Function]
   748   C0680095:failure [Individual Behavior]
   748   C1314939:Involved [Functional Concept]
Processing 00000000.tx.67: Autoimmune diseases have a significantly higher incidence in young women than in men (14). 

Phrase: "Autoimmune diseases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004364:Autoimmune Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0443146:Autoimmune [Pathologic Function]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "a significantly higher incidence in young women"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021149:Incidence [Quantitative Concept]
   748   C0220856:incidence [Functional Concept]

Phrase: "than"

Phrase: "in men (14"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: ")."
Processing 00000000.tx.68: Much of this differential has been attributed to the effects of androgens and estrogens on components of the immune system reviewed in (15). 

Phrase: "Much of this differential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443199:Differential [Qualitative Concept]
   770   C1705242:Differential [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to the effects of androgens"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   767   C3179300:Androgen Effects [Physiologic Function]
   753   C0002844:Androgens [Hormone,Pharmacologic Substance]
   753   C1280500:effects [Qualitative Concept]
   719   C0449234:Attribute [Idea or Concept]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
   719 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "estrogens on components of the immune system"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   714 E C2936882:Estrogen [Pharmacologic Substance]

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "in (15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.69: However, studies also implicate the high levels of progesterone during pregnancy in the suppression of immune function and transitory thymic involution. 

Phrase: "However,"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "also"

Phrase: "implicate"

Phrase: "the high levels of progesterone"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0428409:levels progesterone [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "during pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "in the suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0221103:Suppression [Pathologic Function]
  1000   C0301625:Suppression [Organism Function]
  1000   C0439181:% suppression [Quantitative Concept]
  1000   C0728721:suppression [Mental Process]

Phrase: "of immune function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1817756:Immune Function [Organ or Tissue Function]
   861   C0031843:function [Physiologic Function]
   861   C0439662:Immune [Functional Concept]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "transitory thymic involution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333953:Involution [Organism Function]
Processing 00000000.tx.70: Experimental evidence suggests that androgens and estrogens exert effects on the development of immune cells through their effects on the thymus and bone marrow. 

Phrase: "Experimental evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002844:Androgens [Hormone,Pharmacologic Substance]
   966 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "effects on the development of immune cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "through their effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "on the thymus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040113:Thymus [Body Part, Organ, or Organ Component]
  1000   C1015036:Thymus [Plant]
  1000   C1515430:THYMUS [Tissue]
   944 E C1306748:Thymus gland [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "bone marrow."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]
Processing 00000000.tx.71: In addition, there is evidence that androgens and estrogens have effects on peripheral immune cells involved in cell-mediated immunity. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002844:Androgens [Hormone,Pharmacologic Substance]
   966 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "have"

Phrase: "effects on peripheral immune cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell-mediated immunity."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0020966:Cell-Mediated Immunity [Organism Function]
   923   C3536823:Cell-mediated Immunity [Cell Function]
   812   C0020964:Immunity [Physiologic Function]
   741 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.72: These effects include enhancement of T cell suppressor activity by androgens and enhancement of T cell helper activity by estrogens. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "enhancement of T cell suppressor activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]
   748   C1707919:Enhanced Activity [Quantitative Concept]

Phrase: "by androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002844:Androgens [Hormone,Pharmacologic Substance]
   966 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "enhancement of T cell helper activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]
   748   C1707919:Enhanced Activity [Quantitative Concept]

Phrase: "by estrogens."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.73: Androgens and estrogens also appear to have effects on humoral immunity, and there is evidence that androgens diminish autoreactive antibodies while estrogens increase autoreactive antibodies. 

Phrase: "Androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002844:Androgens [Hormone,Pharmacologic Substance]
   966 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "estrogens also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   827 E C2936882:Estrogen [Pharmacologic Substance]
   777 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "effects on humoral immunity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that androgens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0002844:Androgens [Hormone,Pharmacologic Substance]
   966 E C3536949:Androgen [Pharmacologic Substance]

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "autoreactive antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "while"

Phrase: "estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "autoreactive antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.74: The effects of sex steroids on immune cell function could thus be a contributing factor to the development and progression of autoimmune POF. 

Phrase: "The effects of sex steroids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on immune cell function"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C2346474:Immune Cell Function [Research Activity]
   913   C1817756:Immune Function [Organ or Tissue Function]
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0439662:Immune [Functional Concept]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "could"

Phrase: "thus"

Phrase: "be"

Phrase: "a contributing factor to the development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "progression of autoimmune POF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
Processing 00000000.tx.75: It is clear that significant new information has come from animal models of autoimmune POF that have expanded our understanding of the disease and given clues to potential etiologies. 

Phrase: "It"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that significant new information"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C3242228:new information [Intellectual Product]
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "has"

Phrase: "come from animal models of autoimmune POF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   790   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   790   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   764   C0599779:Models, Animal [Animal]
   764   C0747102:Ovarian failure [Disease or Syndrome]
   742   C0003062:Animal [Animal]
   742   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   742   C0205252:Premature [Temporal Concept]
   742   C0231174:Failure [Functional Concept]
   742   C0443146:Autoimmune [Pathologic Function]
   742   C0680095:failure [Individual Behavior]
   742   C3161035:Models [Intellectual Product]

Phrase: "that"

Phrase: "have"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "our understanding of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "and"

Phrase: "given clues to potential etiologies."
Processing 00000000.tx.76: In addition, these models could ultimately provide screening reagents for early stages of POF in humans. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "these models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "could"

Phrase: "ultimately"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "screening reagents for early stages of POF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.77: The power of the thymectomized mouse model system employed by Tong and Nelson (10) includes the ability to identify genes that are critical for the development of autoimmune POF and then perform genetic manipulations to test their importance. 

Phrase: "The power of the thymectomized mouse model system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "employed by Tong"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0183964:Tong [Medical Device]
   790   C0557351:Employed [Finding]
   756 E C0457083:Employ [Functional Concept]

Phrase: "and"

Phrase: "Nelson"

Phrase: "(10"

Phrase: ")"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "identify"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "critical for the development of autoimmune POF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "genetic manipulations to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0178659:genetic manipulation [Molecular Biology Research Technique]
   827   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   827   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "their importance."
Processing 00000000.tx.78: For example, if the autoimmune susceptibility gene in the Aod2 locus is identified, transgenic mice could be generated with targeted gene disruption in susceptible strains and introduction of the gene to resistant strains. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "if"

Phrase: "the autoimmune susceptibility gene in the Aod2 locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0919453:Susceptibility Gene [Gene or Genome]
   767   C1708726:Gene Locus [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "could"

Phrase: "be"

Phrase: "generated with targeted gene disruption"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1332838:Target Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0332453:Disruption [Functional Concept]
   760   C1521840:Targeted [Functional Concept]
   760   C3146294:Generated [Activity]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in susceptible strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "introduction of the gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1293116:Introduction [Health Care Activity]
   770   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "to resistant strains."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0332325:Resistant [Functional Concept]
   861   C0456178:strains [Intellectual Product]
   861   C2827757:RESISTANT [Laboratory or Test Result]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]
   805 E C0180860:Filter [Manufactured Object]
   805 E C0581406:Filter [Medical Device]
   805 E C1522664:Filter [Intellectual Product]
   805 E C1704449:Filter [Conceptual Entity]
   805 E C1704684:Filter [Medical Device]
   805 E C1875155:FILTER [Medical Device]
   777 E C0442694:Straining [Physiologic Function]
Processing 00000000.tx.79: These animals could then be tested for the development of autoimmune POF after neonatal thymectomy. 

Phrase: "These animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "could"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "tested for the development of autoimmune POF"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   790   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   790   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   790   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   764   C0747102:Ovarian failure [Disease or Syndrome]
   762   C1160265:ovarian development [Organ or Tissue Function]
   742   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   742   C0205252:Premature [Temporal Concept]
   742   C0231174:Failure [Functional Concept]
   742   C0243107:development [Physiologic Function]
   742   C0392366:tested [Intellectual Product]
   742   C0443146:Autoimmune [Pathologic Function]
   742   C0678723:Development [Organism Function]
   742   C0680095:failure [Individual Behavior]
   742   C1527148:Development [Functional Concept]
   708 E C0022885:Test [Laboratory Procedure]
   708 E C0039593:Test [Functional Concept]

Phrase: "after neonatal thymectomy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040071:Thymectomy [Therapeutic or Preventive Procedure]
   861   C2945605:Thymectomy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.80: The data from these animal models could therefore have important implications to our understanding of autoimmune POF and possibly provide information on potential treatment strategies.  

Phrase: "The data from these animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0597710:animal data [Intellectual Product]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "could"

Phrase: "therefore"

Phrase: "have"

Phrase: "important implications to our understanding of autoimmune POF"

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "information on potential treatment strategies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2708734:Treatment information [Clinical Attribute]
   797   C2708735:Treatment information [Intellectual Product]
   760   C1533716:Information [Idea or Concept]
Processing 00000000.tx.81: Footnotes  1 F.A.F. is supported by NIH Training Grant 5T3-HD-07043. 

Phrase: "Footnotes  1 F.A.F."

Phrase: "is"

Phrase: "supported by NIH Training Grant 5T3-HD-07043."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0555633:Training grant [Intellectual Product]
   750   C0040608:Training Support [Educational Activity]
   744   C0018173:Grant [Quantitative Concept]
   744   C0027468:NIH [Health Care Related Organization]
   744   C0040607:Training [Educational Activity]
   744   C0220931:Training [Educational Activity]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C2673163:training [Qualitative Concept]
   711 E C0183683:Support [Medical Device]
   711 E C0336809:Train [Manufactured Object]
   711 E C1552514:Train [Manufactured Object]
Processing 00000000.tx.82: Received June 1, 1999.  

Phrase: "Received June 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1999."
Processing 00000000.tx.83: References Top Abstract Introduction References  Hoek A, Schoemaker J, and Drexhage HA 1997 Premature ovarian failure and ovarian autoimmunity. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1293116:Introduction [Health Care Activity]
   827   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hoek A,"

Phrase: "Schoemaker J,"

Phrase: "and"

Phrase: "Drexhage HA 1997 Premature ovarian failure"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   861   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   861   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   827   C0747102:Ovarian failure [Disease or Syndrome]
   799   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   799   C0205252:Premature [Temporal Concept]
   799   C0231174:Failure [Functional Concept]
   799   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "ovarian autoimmunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004368:Autoimmunity [Pathologic Function]
   789 E C0443146:Autoimmune [Pathologic Function]
Processing 00000000.tx.84: Endocr Rev 18:107134[Abstract/Free FullText] Kalantaridou SN, Davis SR, Nelson LM 1998 Premature ovarian failure. 

Phrase: "Endocr Rev 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "107134"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kalantaridou SN,"

Phrase: "Davis SR,"

Phrase: "Nelson LM 1998 Premature ovarian failure."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   861   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   861   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   827   C0747102:Ovarian failure [Disease or Syndrome]
   799   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   799   C0205252:Premature [Temporal Concept]
   799   C0231174:Failure [Functional Concept]
   799   C0680095:failure [Individual Behavior]
Processing 00000000.tx.85: Endocrinology and Metabolism Clinics of North America 27:9891006[Medline] Tung KSK, Lou YH, Garza KM, Teuscher C 1997 Autoimmune ovarian disease: mechanism of disease induction, and prevention. 

Phrase: "Endocrinology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "and"

Phrase: "Metabolism Clinics of North America 27"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0442592:clinics [Health Care Related Organization,Manufactured Object]
   719 E C0002424:Clinic [Health Care Related Organization,Manufactured Object]

Phrase: ":"

Phrase: "9891006"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tung KSK,"

Phrase: "Lou YH,"

Phrase: "Garza KM,"

Phrase: "Teuscher C 1997 Autoimmune ovarian disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   839   C0004364:Autoimmune Disease [Disease or Syndrome]
   827   C0029928:Ovarian Disease [Disease or Syndrome]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "mechanism of disease induction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "prevention."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.86: Curr Opin Immunol 9:839845[CrossRef][Medline] Krohn K, Uibo R, Aavik E, Petersen P, Savilahti K 1992 Identification by molecular cloning of an autoantigen associated with Addisons disease as steroid 17-hydroxylase. 

Phrase: "Curr Opin Immunol 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "839845"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krohn K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Uibo R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Aavik E,"

Phrase: "Petersen P,"

Phrase: "Savilahti K 1992 Identification by molecular cloning of an autoantigen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0020792:Identification [Mental Process]
   739   C0205396:Identification [Qualitative Concept]

Phrase: "associated with Addisons disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0001403:Addison Disease [Disease or Syndrome]
   833   C0266273:ADDISON DISEASE [Congenital Abnormality,Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "as steroid 17-hydroxylase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038302:Steroid 17-Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
           17-Hydroxylase
   913   C0038311:steroid hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0599930:steroid hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.87: Lancet 339:770773[Medline] Winqvist O, Gustafsson J, Rorsman F, Karlsson FA 1993 Two different cytochrome P 450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type 1 and Addisons disease. 

Phrase: "Lancet 339"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "770773"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Winqvist O,"

Phrase: "Gustafsson J,"

Phrase: "Rorsman F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Karlsson FA 1993 Two different cytochrome P 450 enzymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   832   C0010762:Cytochrome p-450 enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0014442:Enzymes [Enzyme,Organic Chemical]
   791   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "the adrenal antigens in autoimmune polyendocrine syndrome type 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1291774:antigens type [Immunologic Factor]
   745 E C0449568:Antigen type [Intellectual Product]
   742   C0003320:Antigens [Immunologic Factor]

Phrase: "and"

Phrase: "Addisons disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0001403:Addison Disease [Disease or Syndrome]
  1000   C0266273:ADDISON DISEASE [Congenital Abnormality,Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.88: J Clin Invest 92:23772385[Medline] Arif S, Vallian S, Farzaneh F, Zanone MM, James SL, Pietropaolo M, Hettiarachchi S, Vergani D, Conway GS, Peakman M 1996 Identification of 3-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: Association of autoantibodies with endocrine autoimmune disease. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "92"

Phrase: ":"

Phrase: "23772385"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Arif S,"

Phrase: "Vallian S,"

Phrase: "Farzaneh F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Zanone MM,"

Phrase: "James SL,"

Phrase: "Pietropaolo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hettiarachchi S,"

Phrase: "Vergani D,"

Phrase: "Conway GS,"

Phrase: "Peakman M 1996 Identification of 3-hydroxysteroid dehydrogenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "as a novel target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "of steroid cell autoantibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Association of autoantibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "with endocrine autoimmune disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0014130:Endocrine disease [Disease or Syndrome]
   901   C0004364:Autoimmune Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0443146:Autoimmune [Pathologic Function]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.89: J Clin Endocrinol Metab 81:44394445[Abstract] Coulam CB, Stringfellow S, Hoefnagel D 1983 Evidence for a genetic factor in the etiology of premature ovarian failure. 

Phrase: "J Clin Endocrinol Metab 81"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "44394445"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Coulam CB,"

Phrase: "Stringfellow S,"

Phrase: "Hoefnagel D 1983 Evidence for a genetic factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "in the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of premature ovarian failure."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
  1000   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
  1000   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   901   C0747102:Ovarian failure [Disease or Syndrome]
   827   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   827   C0205252:Premature [Temporal Concept]
   827   C0231174:Failure [Functional Concept]
   827   C0680095:failure [Individual Behavior]
Processing 00000000.tx.90: Fertil Steril 40:693695[Medline] Mattison DR, Evans MI, Schwimmer WB, White BJ, Jensen B, Schulman JD 1984 Familial premature ovarian failure. 

Phrase: "Fertil Steril 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "693695"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattison DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Evans MI,"

Phrase: "Schwimmer WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: "White BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Jensen B,"

Phrase: "Schulman JD 1984 Familial premature ovarian failure."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   877   C2930861:Premature ovarian failure, familial [Disease or Syndrome]
   845   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   845   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   845   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   818   C0747102:Ovarian failure [Disease or Syndrome]
   795   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   795   C0205252:Premature [Temporal Concept]
   795   C0231174:Failure [Functional Concept]
   795   C0680095:failure [Individual Behavior]
Processing 00000000.tx.91: Am J Hum Genet 36:13421348 Teuscher C, Wardell BB, Lunceford JK, Michael SD, Tung KSK 1996 Aod2, the locus controlling atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes with Il2, Fgfb, and Idd3. 

Phrase: "Am"

Phrase: "J Hum Genet 36"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "13421348 Teuscher C,"

Phrase: "Wardell BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Lunceford JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Michael SD,"

Phrase: "Tung KSK 1996 Aod2,"

Phrase: "the locus controlling atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0404445:Ovarian atrophy [Acquired Abnormality]
   738   C0333641:Atrophy [Pathologic Function]

Phrase: "co-localizes with Il2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0021756:IL2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0392752:localize [Spatial Concept]
   770   C0879590:IL2 [Gene or Genome]

Phrase: "Fgfb,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919506:FGFB [Gene or Genome]
  1000   C1708015:FGFB [Gene or Genome]

Phrase: "and"

Phrase: "Idd3."
Processing 00000000.tx.92: J Exp Med 183:631637[Abstract] Tong Z-B, Nelson LM 1999 A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. 

Phrase: "J Exp Med 183"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "631637"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tong Z-B,"

Phrase: "Nelson LM 1999"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1261082:LM [Body Part, Organ, or Organ Component]
   827   C1551056:lm [Quantitative Concept]
   827   C2981682:LM [Quantitative Concept]

Phrase: "A mouse gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "an oocyte antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003320:Antigen [Immunologic Factor]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "associated with autoimmune premature ovarian failure."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0025322:Premature Ovarian Failure [Disease or Syndrome]
           Ovarian Failure
   833   C0085215:Ovarian Failure, Premature [Disease or Syndrome]
   833   C3494522:OVARIAN FAILURE, PREMATURE [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0747102:Ovarian failure [Disease or Syndrome]
   753   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   753   C0205252:Premature [Temporal Concept]
   753   C0231174:Failure [Functional Concept]
   753   C0443146:Autoimmune [Pathologic Function]
   753   C0680095:failure [Individual Behavior]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.93: Endocrinology 140:00000000 Martimbeau S, Tilly JL 1997 Physiological cell death in endocrine-dependent tissues: an ovarian perspective. 

Phrase: "Endocrinology 140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "00000000 Martimbeau S,"

Phrase: "Tilly JL 1997 Physiological cell death in endocrine-dependent tissues"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0007587:Cell Death [Cell Function]
   757   C0229525:Endocrine cell [Cell]
   741   C0027540:death tissue [Organ or Tissue Function]
   739   C0007634:Cell [Cell]
   739   C0011065:Death [Organism Function]
   739   C1269647:Cell [Cell]
   739   C1306577:Death, NOS [Finding]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   722   C0007613:Cell physiology [Cell Function]
   722   C1325880:cell physiology [Cell Function]

Phrase: ":"

Phrase: "an ovarian perspective."
Processing 00000000.tx.94: Clin Endocrinol 46:241254[Medline] Billig H, Chun S-Y, Eisenhauer K, Hsueh AJW 1996 Gonadal cell apoptosis: hormone-regulated cell demise. 

Phrase: "Clin Endocrinol 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "241254"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Billig H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chun"

Phrase: "S-"

Phrase: "Y,"

Phrase: "Eisenhauer K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hsueh AJW 1996 Gonadal cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0162638:Apoptosis [Cell Function]
   727 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "hormone-regulated cell demise."
Processing 00000000.tx.95: Hum Reprod Update 2:103117[Abstract/Free FullText] McGee EA, Hsu S-Y, Kaipia A, Hsueh AJW 1998 Cell death, and survival during ovarian follicle development. 

Phrase: "Hum Reprod Update 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1519814:Update [Temporal Concept]

Phrase: ":"

Phrase: "103117"

Phrase: "[Abstract/Free FullText"

Phrase: "] McGee EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Hsu"

Phrase: "S-"

Phrase: "Y,"

Phrase: "Kaipia A,"

Phrase: "Hsueh AJW 1998 Cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "survival during ovarian follicle development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
Processing 00000000.tx.96: Mol Cell Endocrinol 140:1518[CrossRef][Medline] Lahita RG 1997 Predisposing factors to autoimmune disease. 

Phrase: "Mol Cell Endocrinol 140"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "1518"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lahita RG 1997 Predisposing factors to autoimmune disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032946:Predisposing Factors [Temporal Concept]
   767   C0679238:disease factors [Functional Concept]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.97: Int J Fertil 42:115119 Olsen NJ, Kovacs WJ 1996 Gonadal steroids, and immunity. 

Phrase: "Int J Fertil 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0063789:INT [Organic Chemical]
   812   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "115119 Olsen NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027971:NJ [Geographic Area]

Phrase: "Kovacs WJ 1996 Gonadal steroids,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0036884:gonadal steroids [Hormone,Pharmacologic Substance]
   804   C0038317:Steroids [Steroid]

Phrase: "and"

Phrase: "immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020964:Immunity [Physiologic Function]
   928 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.98: Endocr Rev 17:369384

Phrase: "Endocr Rev 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "369384"

